SEC Form 4 · accession 0001104659-17-033512
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Aryeh
Director
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | May 15, 2017 | P | 361 | $8.95 | A | 242,433 | D | |
| Common SharesF1,F2 | holding | — | — | — | 127,491 | I | By JALAA Equities, L.P. | |
| Common SharesF1,F2 | holding | — | — | — | 6,256 | I | By JLV Investments, LP | |
| Common SharesF1,F2 | holding | — | — | — | 16,553 | I | By JLD Investments, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a one-for-five share consolidation of the common shares of the Issuer effective December 16, 2016.
- F2The Reporting Person disclaims beneficial ownership except to the extent of the Reporting Person's pecuniary interest.